Australian Patent Journal Round-Up 16 January 2014 – 10 April 2014

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 16 January 2014 – 10 April 2014.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.

Please note that the information in the tables below is correct as at the date of the Patent Office Journal but is subject to change.  Please check AUSPAT for the current status of any of the patents below.

 

Opposition Proceedings

 Opposition Lodged

Acceptance of the following patent applications has been opposed:

Application No. Title Applicant(s) Opponent(s)
2006336598 Glaucoma treatment device Transcend Medical, Inc. Glaukos Corporation
2007229741 Data storage medium and method for manufacturing it Giesecke & Devrient GmbH Innovia Security Pty
2010294852 Elongated security feature comprising machine-readable magnetic regions Giesecke & Devrient GmbH Innovia Security Pty Ltd
2010332441 Method of treating wastewater and producing an activated sludge having a high biopolymer production potential Veolia Water Solutions & Technologies Support Paques B.V.
2007224116 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production ViaCyte, Inc. BioTime, Inc.
2009336797 Dye Solution Fluoron GmbH D.O.R.C. Dutch Ophthalmic Research Center (International) BV
2010202253 Compositions, methods and systems for inferring bovine traits Cargill, Inc.; Branhaven LLC IP Organisers Pty. Ltd.
2013204930 Therapeutics using multiple injections of cells Cell Ideas Pty Ltd Magellan Stem Cells Pty Ltd
2011201004 A method and system for gaming SHFL Entertainment (Australasia) Pty Limited Aristocrat Technologies Australia Pty Limited
2011213836 Bioeffective krill oil compositions Aker Biomarine AS Olympic Seafood AS
2013202342 Wear assembly Esco Corporation Caterpillar Inc.
2007215334 Polynucleotides and polypeptide sequences involved in the process of bone remodeling Alethia Biotherapeutics Inc. Daiichi Sankyo Company Limited
2010230688 Mobile crusher TAKRAF GmbH ThyssenKrupp Industrial Solutions GmbH
2010276161 Method for evaluating shaped charge perforation test cores using computer tomographic images thereof InGrain, Inc. Lithicon Australia Pty Ltd
2013202166 IV Catheter B Braun Melsungen AG Chrysiliou, K.
2010335202 Net replacement film Trioplast AB Combipac B.V.
2012212405 A hose deployment device Innovation Realisation Pty Ltd The Crown in the Right of the State of New South Wales (Fire and Rescue NSW)
2007335195 Artificial selection method and reagents Agriculture Victoria Services Pty Limited Meat & Livestock Australia Limited
2012222102 Lightweight, reduced density fire rated gypsum panels United States Gypsum Company CSR Building Products Limited
2009204252 Portable multifunction device with interface reconfiguration mode Apple Inc. Fisher, G.

Opposition Withdrawn

Opposition to acceptance of the following applications have been withdrawn:

Application No. Title Applicant(s) Opponent(s)
2007309154 Reclosable packages for confectionery products Wm. Wrigley, Jr. Company KRAFT FOODS GLOBAL BRANDS LLC
2008291978 A new method for making krill meal Aker Biomarine AS Neptune Technologies & Bioressources Inc.
2006230761 Patterned optical structures with enhanced security feature JDS Uniphase Corporation Securency International Pty Ltd
2007326985 Modified soluble FGF receptor Fc fusions with improved biological activity Aventis Pharma S.A. Five Time Therapeutic,Inc
2005234498 Multicasting multimedia content distribution system TiVo Inc. FOXTEL Management Pty Ltd
2005306361 Method and apparatus for secure transfer of previously broadcasted content TiVo Inc. FOXTEL Management Pty Ltd
2005306362 Method and apparatus for secure transfer and playback of multimedia content TiVo Inc. FOXTEL Management Pty Ltd
2006344734 Method and apparatus for secure transfer and playback of multimedia content TiVo Inc. FOXTEL Management Pty Ltd
2006344735 In-band data recognition and synchronization system TiVo Inc. FOXTEL Management Pty Ltd
2007224180 Customizing DVR functionality TiVo Inc. FOXTEL Management Pty Ltd
2007225374 Recommended recording and downloading guides TiVo Inc. FOXTEL Management Pty Ltd
2007269944 Method and apparatus for advertisement placement in a user dialog on a set-top box TiVo Inc. FOXTEL Management Pty Ltd
2007294935 Personal content distribution network TiVo Inc. FOXTEL Management Pty Ltd
2007314276 Method for enhancing television advertising viewership TiVo Inc. FOXTEL Management Pty Ltd
2008205164 Authorable content rating system TiVo Inc. FOXTEL Management Pty Ltd
2008254894 Multimedia content search and recording scheduling system TiVo Inc. FOXTEL Management Pty Ltd
2008254906 Media data content search system TiVo Inc. FOXTEL Management Pty Ltd
2008337508 Compressible decorative paper impregnating agent which can be printed by the inkjet method TECHNOCELL DEKOR GMBH & CO. KG Laminex Group Pty Limited
2009202614 Automatic detection of program subject matter and scheduling padding TiVo Inc. FOXTEL Management Pty Ltd
2011202891 A lockable chain winder ASSA ABLOY Australia Pty Limited Pacific Enterprises (Aust) Pty Ltd
2005202186 Edging improvements Haysom, D.; Haysom, R. Curv-Rite, Inc.
2009243527 Controlled release formulation Euro-Celtique S.A. Sandoz Pty Ltd
2008253590 Vibrating screen panel Ludowici Australia Pty Ltd Schenk Process Australia Pty Ltd

 

Opposition Dismissed

Application No. Title Applicant(s) Opponent(s)
2004281345 Al-Mg-Si alloy suited for extrusion Norsk Hydro ASA Rio Tinto Alcan International Limited
2005238278 Sacrificial anode assembly Vector Corrosion Technologies Ltd Concrete Preservation Technologies Ltd
2003258753 Diesel fuel composition, comprising components based on biological raw material, obtained by hydrogenating and decomposition fatty acids Neste Oil Oyj BP International Limited

 

Applications Withdrawn

Application No. Title Applicant(s) Opponent(s)
2008202359 Modular lng process BP Corporation North America Inc. Woodside Energy Limited
2008247331 Improvements in the manufacture of B-stage resin impregnated papers or non-wovens Depco-TRH Pty Ltd Laminex Group Pty Limited
2006254436 Data carrier and method for the production thereof Giesecke & Devrient GmbH Securency International Pty Ltd
2007229741 Data storage medium and method for manufacturing it Giesecke & Devrient GmbH Innovia Security Pty Ltd
2005299246 Energy management method and system Dux Manufacturing Limited Rheem Australia Pty Limited
2005330654 Dosage forms of risedronate Warner Chilcott Company, LLC Apotex Pty Ltd
2009200048 Marine power distribution and propulsion systems Converteam Technology Ltd SIEMENS AG
2009286034 Optimized flavored polymeric compositions A. Schulman, Inc. Shock Doctor, Inc.

 

Extensions of Term of Standard Patents

Applications Filed

   Title Applicant Reg Aprroval Date & Goods
2002330681 Vaccines comprising aluminium adjuvants and histidine Novartis Vaccines and Diagnostics S.r.l. 14 Aug 2013
BEXSERO
2005260243 A combination composition AFT Pharmaceuticals Limited 23 Dec 2013
MAXIGESIC maxigesic
2002339217 Hybrid and tandem expression of Neisserial proteins Novartis Vaccines and Diagnostics S.r.l 14 Aug 2013
BEXSERO
2002344419 Alpha-form or beta-form cyrstal of acetanilide derivative Astellas Pharma Inc. 17 Oct 2013
BETMIGA mirabegron
2003274511 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages Novartis Vaccines and Diagnostics S.r.l. 14 Aug 2013
BEXSERO
2006201153 Combination Neisserial compositions Novartis Vaccines and Diagnostics S.r.l. 14 Aug 2013
BEXSERO
2008234959 Hybrid and tandem expression of Neisserial proteins Novartis Vaccines and Diagnostics S.r.l. 14 Aug 2013
BEXSERO
2004260761 Novel compounds having inhibitory activity against sodium-dependent transporter Mitsubishi Tanabe Pharma Corporation 12 Sep 2013
INVOKANA canagliflozin (as hemihydrate)
2004318013 Dipeptidyl peptidase inhibitors Takeda Pharmaceutical Company Limited 17 Sep 2013
NESINA alogliptin (as benzoate)
2006283726 Process for preparing maytansinoid antibody conjugates ImmunoGen, Inc. 03 Sep 2013
KADCYLA trastuzumab emtansine rch
2007329895 Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate Mitsubishi Tanabe Pharma Corporation 12 Sep 2013
INVOKANA canagliflozin (as hemihydrate)
2002344182 Influenza vaccine composition GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG 28 Aug 2013
FLUARIX TETRA inactivated split influenza vaccine suspension for injection
2004215428 Aminoheteroaryl compounds as protein kinase inhibitors Sugen, Inc. 27 Sep 2013
XALKORI crizotinib
2004251866 Pharmaceutical composition comprising cyclic somatostatin analogues Novartis AG 01 Nov 2013
SIGNIFOR pasireotide
2004282491 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates ImmunoGen, Inc. 03 Sep 2013
KADCYLA (trastuzumab emtansine rch)
2005249490 Antibody drug conjugates and methods Genentech, Inc. 03 Sep 2013
KADCYLA (trastuzumab emtansine rch)
2006200742 Novel vaccine composition GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG 28 Aug 2013
FLUARIX TETRA inactivated split influenza vaccine suspension for injection
2006263964 Immunogenic composition GlaxoSmithKline Biologicals S.A. 29 Aug 2013
NIMENRIX meningococcal (groups A,C,W-135,Y) poly saccharide tetanus toxoid conjugate vaccine
2006323025 Polymorphs of a c-Met/HGFR inhibitor Pfizer Products Inc. 27 Sep 2013
XALKORI crizotinib
2009202707 Human antibodies that bind human TNFalpha AbbVie Biotechnology Ltd 10 Dec 2003
HUMIRA adaliimumab (rch)
2003244799 Combination of azelastine and steroids Cipla Limited 14 Jan 2014
DYMISTA azelastine hydrochloride and fluticasone propionate
2005276132 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors Pfizer Inc. 27 Sep 2013
XALKORI crizotinib
2005276135 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors Pfizer Inc. 27 Sep 2013
XALKORI crizotinib

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Applications Accepted

Patent No Title Applicant Reg Aprroval Date & Goods
2005258320 Modulators of ATP-Binding Cassette transporters Vertex Pharmaceuticals Incorporated 09 Jul 2013
KALYDECO (ivacaftor)
2010249302 Modulators of ATP-Binding Cassette Transporters Vertex Pharmaceuticals Incorporated 09 Jul 2013
KALYDECO (ivacaftor)
2004319756 Polymer-based sustained release device Alkermes, Inc.; Amylin Pharmaceuticals, Inc. 20 Dec 2012
BYDUREON exenatide
2004318013 Dipeptidyl peptidase inhibitors Takeda Pharmaceutical Company Limited 17 Sep 2013
NESINA alogliptin (as benzoate)
2006332726 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Vertex Pharmaceuticals Incorporated. 09 Jul 2013
KALYDECO (ivacaftor)
2004215428 Aminoheteroaryl compounds as protein kinase inhibitors Sugen, Inc. 27 Sep 2013
XALKORI crizotinib
2004260761 Novel compounds having inhibitory activity against sodium-dependent transporter Mitsubishi Tanabe Pharma Corporation 27 Sep 2013
INVOKANA canagliflozin (as hemihydrate)
2005276132 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors Pfizer Inc. 27 Sep 2013
XALKORI crizotinib
2005276135 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors Pfizer Inc. 27 Sep 2013
XALKORI crizotinib
2007329895 Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate Mitsubishi Tanabe Pharma Corporation 12 Sep 2013
INVOKANA canagliflozin (as hemihydrate)
2001289778 Somatostatin analogues Novartis AG 01 Nov 2013
SIGNIFOR pasireotide
2003244799 Combination of azelastine and steroids Cipla Limited 14 Jan 2014
DYMISTA azelastine hydrochloride and fluticasone propionate
2004251866 Pharmaceutical composition comprising cyclic somatostatin analogues Novartis AG 01 Nov 2013
SIGNIFOR pasireotide
2005260243 A combination composition AFT Pharmaceuticals Limited 23 Dec 2013
MAXIGESIC maxigesic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Extensions granted

Patent No Title Applicant Approval Date & Goods Expiry Date
2005287404 HER2 antibody composition Genentech, Inc. 6 May 2013
PERJETA pertuzumab
22 Jul 2028
2005295394 Antibody formulation in histidine-acetate buffer Genentech, Inc. 6 May 2013
PERJETA pertuzumab
06 May 2028
2008261137 Antibodies to OPGL Amgen Inc.; Amgen Fremont Inc. 07 Jun 2010
PROLIA denosumab
06 May 2028
2009217435 Xanthine derivative, production and use thereof as a medicament Boehringer Ingelheim Pharma GmbH & Co. KG 01 Nov 2011
TRAJENTA linagliptin
07 Jun 2025
2010200660 The treatment of respiratory diseases Sosei R&D Ltd. 12 Nov 2012
TOVANOR BREEZHALER glycopyrronium
09 Apr 2025

 

 

 

 

 

 

 

Surrendered and Revoked Letters Patent

Surrendered Letters Patent

Patent No. Title Patentee Date of Patent
2010100507 Document classification toolbar Titus Inc 10.06.2010
2011100458 A solar air heating system with a heat storage Sokolov 19.05.2011

Revocation of Letters Patent

Patent No. Title Patentee Date of Patent
2007237237 Organic photosensitive optoelectronic device The Trustees of Princeton University 12.12.2013
2006269934 Treatment of cancer Bipar Sciences, Inc. 09.01.2014
2012101554 Conjugation process of bacterial polysaccharides to carrier proteins GlaxoSmithKline Biologicals s.a. 16.01.2014
2013101517 PIPE SYSTEM AND BUILDING DESIGN Sellick ConsultantsPty Ltd 30.01.2014

 

 

 

 

 

 

BCSE(Hons) MIP FIPTA

Mark’s academic background is in computer science and electrical engineering. He assists clients in obtaining and enforcing their intellectual property rights in the areas of software, electronics and engineering. Prior to joining Phillips Ormonde Fitzpatrick, Mark worked for a leading automotive manufacturer.